| 2024-01-17 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Operating Officer | 18,908 0.0078% | $0.67 | $12,725 | +61.54% | |
| 2024-01-16 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Operating Officer | 4,681 0.0023% | $0.79 | $3,698 | +61.95% | |
| 2024-01-12 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Operating Officer | 5,220 0.0024% | $0.85 | $4,458 | +39.46% | |
| 2024-01-11 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Operating Officer | 4,009 0.0017% | $0.84 | $3,354 | +33.35% | |
| 2023-01-17 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Operating Officer | 4,440 0.0029% | $1.86 | $8,250 | -47.31% | |
| 2023-01-12 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Operating Officer | 4,973 0.0028% | $1.71 | $8,484 | -49.29% | |
| 2023-01-11 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Operating Officer | 3,843 0.0023% | $1.75 | $6,713 | -48.1% | |
| 2023-01-04 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Operating Officer | 3,584 0.0021% | $1.69 | $6,071 | -47.5% | |
| 2022-01-18 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Operating Officer | 4,368 0.0029% | $3.19 | $13,942 | -40.52% | |
| 2022-01-12 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Operating Officer | 2,248 0.0015% | $3.54 | $7,967 | -46.49% | |
| 2022-01-11 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Operating Officer | 3,770 0.0024% | $3.56 | $13,409 | -48.88% | |
| 2022-01-04 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Operating Officer | 3,490 0.0024% | $4.06 | $14,184 | -52.08% | |
| 2021-07-02 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Operating Officer | 4,375 0.0028% | $4.26 | $18,659 | -18.56% | |
| 2021-01-12 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Operating Officer | 2,234 0.0015% | $6.15 | $13,744 | -15.45% | |
| 2021-01-04 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Operating Officer | 3,499 0.002% | $5.33 | $18,642 | -16.14% | |
| 2020-12-14 | Adaptimmune Therapeutics plc ADAP | Chief Operating Officer | 207,000 0.0227% | $0.69 | $143,824 | +23.78% | ||
| 2020-01-14 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Operating Officer | 2,397 0.0025% | $5.13 | $12,308 | +28.47% | |
| 2020-01-06 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Operating Officer | 3,731 0.003% | $1.20 | $4,477 | +310.74% | |
| 2019-01-14 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Operating Officer | 4,542 0.0043% | $5.37 | $24,388 | -35.9% | |
| 2015-12-17 | Ardelyx, Inc. ARDX | director | 10,000 0.0448% | $20.00 | $200,000 | -47.38% |